Skip to main navigation
Skip to search
Skip to main content
Columbia University Home
Help & FAQ
English
Français
Español
Home
Profiles
Research units
Research output
Equipment
Datasets
Projects & Clinical Trials
Activities
Prizes
Courses
Student theses
Search by expertise, name or affiliation
DBLE BLIND RANDOM PLACEBO CONT TRIAL ALENDRONATE IN PRIM HYPERPARATH
Bilezikian, John Paul
(PI)
Vagelos College of Physicians and Surgeons
Project
:
Research project
Overview
Fingerprint
Projects & Clinical Trials
(1)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Metronidazole
100%
Alendronic Acid
100%
Placebo
100%
Cotetroxazine
100%
Primary Hyperparathyroidism
45%
Osteopenia
16%
Parathyroid Hormone
9%
Hyperthyroidism
9%
Clinical Trial
9%
Combination Therapy
9%
Treatment Group
9%
Medicine and Dentistry
Alendronic Acid
66%
Cotetroxazine
66%
Placebo
66%
Metronidazole
66%
Isotopes of Calcium
47%
Bone Density
28%
Primary Hyperparathyroidism
28%
Postmenopause
19%
Clinical Trial
9%
Hyperthyroidism
9%
Combination Therapy
9%
Estrogen Therapy
9%
Osteoporosis
9%
Parathyroid Hormone
9%
Osteolysis
9%
Treatment Group
9%
Parathyroid Gland
9%
Urolithiasis
9%